Jump to page content

Search results

  • Press release Corona

    Why some people suffer more from COVID-19 than others

    A large number of people are currently contracting COVID-19. Fortunately, most of them are experiencing only mild symptoms, largely thanks to the high vaccination rate. However, in some individuals the disease takes a much more severe cause and our understanding about the underlying reasons is still insufficient. The human genome may hold a key to…

  • Press release Corona

    What happens in the lungs during SARS-CoV-2 infection

    A Berlin-based research group led by Charité - Universitätsmedizin Berlin has succeeded in simulating SARS-CoV-2 infection in human lungs and has gained important insights into the mechanism of infection. Using living lung samples, they were able to show that the virus is capable of directly infecting the cells of the human alveoli to only a very…

  • Press release Corona

    The fatal role of T cells in COVID-19

    Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Charité – Universitätsmedizin Berlin and the university hospitals in Bonn and Aachen, have found a type of immune cells that is particularly active in severely ill COVID-19 patients. The CD16 positive T cells have an increased cytotoxic effect, especially…

  • Press release Corona

    Multicenter CATCOVID trial for treating severe COVID-19 progression enrolls first patient

    The clinical phase II trial CATCOVID initiated by the Berlin Institute of Health at Charité (BIH) has cleared the final regulatory hurdles with the receipt of a positive ethics committee vote and with approval from the Federal Institute for Drugs and Medical Devices (BfArM), enrolling its first patient this week at University of Leipzig Medical…

  • Press release Corona

    Are we prepared for the next pandemic? BIH and Tagesspiegel jointly hosted the Future Medicine Round Table in early November

    The SARS-CoV-2 coronavirus has had us in its grip for almost two years. Scientists have accomplished a great deal during this time: They have decoded the virus’s genome, developed tests and vaccines, and investigated how the virus takes hold in the body and spreads from person to person. Yet despite all this knowledge, the end is still not in…

  • Press release Corona

    The aftershock of the COVID-19 pandemic and genomic data for global human health: The BIH hosts panel discussions at the World Health Summit

    Although all the world has been focusing on vaccinations, infection rates and ICU occupancy levels, BIH scientists believe the real big wave is still coming: Long COVID. The patients who successfully survived COVID-19 but are still suffering from long-term effects will in all likelihood continue to present a challenge to the healthcare system for a…

  • Press release Corona

    Strong antiviral immunity in the upper airways protects children from severe COVID-19

    Children can also be infected with the novel coronavirus SARS-CoV-2, but have a substantially lower risk for developing severe COVID-19 disease compared to adults. A team of scientists from the Berlin Institute of Health at Charité (BIH), Charité – Universitätsmedizin Berlin, University of Leipzig Medical Center, and the German Cancer Research…

  • Press release Equal Opportunity

    Seniors sought for Wikipedia writing workshop

    The project Hauptstadt der Wissenschaftlerinnen, or Capital of Women in Science – backed by the Berlin Institute of Health at Charité (BIH) and the Berlin Senate Chancellery – wants to raise the visibility of Berlin’s female scientists through Wikipedia articles. Three workshops will give interested members of the public an opportunity to learn…

Press contact

Dr. Stefanie Seltmann

Head of Communications, Press Spokesperson

Contact information
Phone:+49 30 450 543 019
E-mail:stefanie.seltmann@bih-charite.de